Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Convertible Note | Dead

Total Raised


Last Raised


About Consensus Pharmaceuticals

Developer of peptide-based drug discovery technologies. The company makes use of its suite of functional proteomic technologies to rapidly characterize protein binding site requirements (enzyme and receptor) and to assist in cell signaling pathway placement through bioinformatics. With the successful sequencing of the human genome, development of tools to assist in understanding gene function, such as those the company offers, has become the next critical step of research efforts to identify and validate genes as targets for drug discovery. This information allows the rapid initiation of selective HTS assays and focusing of drug discovery programs. Additional the company's technology provides purified, functional G Protein-Coupled Receptors for a range of applications from crystallization studies to the identification of the native ligands of new receptors (de-orphaning) for drug discovery.

Consensus Pharmaceuticals Headquarter Location

200 Boston Avenue

Medford, Massachusetts, 02155,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.